BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36811581)

  • 21. Long Non-Coding RNA
    Di Fazio P; Rusche FD; Roth S; Pehl A; Wächter S; Mintziras I; Bartsch DK; Holzer K
    Cancer Invest; 2022 Mar; 40(3):254-267. PubMed ID: 34726962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic inhibition of polo-like kinases in anaplastic thyroid cancer.
    Lin SF; Yeh CN; Huang YT; Chou TC; Wong RJ
    Cancer Sci; 2021 Feb; 112(2):803-814. PubMed ID: 33306266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
    Wang W; Zhou J; Zhao L; Chen S
    Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death.
    Matrood S; de Prisco N; Wissniowski TT; Wiese D; Jabari S; Griesmann H; Wanzel M; Stiewe T; Neureiter D; Klieser E; Mintziras I; Buchholz M; Bartsch DK; Gennarino VA; Di Fazio P
    Neuroendocrinology; 2021; 111(10):965-985. PubMed ID: 33108790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer.
    Tesselaar MH; Crezee T; Schuurmans I; Gerrits D; Nagarajah J; Boerman OC; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
    J Nucl Med; 2018 May; 59(5):780-786. PubMed ID: 29242405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.
    Catalano MG; Pugliese M; Gargantini E; Grange C; Bussolati B; Asioli S; Bosco O; Poli R; Compagnone A; Bandino A; Mainini F; Fortunati N; Boccuzzi G
    Int J Cancer; 2012 Feb; 130(3):694-704. PubMed ID: 21400508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.
    Di Fazio P; Waldegger P; Jabari S; Lingelbach S; Montalbano R; Ocker M; Slater EP; Bartsch DK; Illig R; Neureiter D; Wissniowski TT
    Oncotarget; 2016 May; 7(20):28998-9010. PubMed ID: 27058414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer.
    Wu J; Liang J; Liu R; Lv T; Fu K; Jiang L; Ma W; Pan Y; Tan Z; Liu Q; Qiu W; Ge M; Wang J
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37283515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.
    Conticello C; Adamo L; Giuffrida R; Vicari L; Zeuner A; Eramo A; Anastasi G; Memeo L; Giuffrida D; Iannolo G; Gulisano M; De Maria R
    J Clin Endocrinol Metab; 2007 May; 92(5):1938-42. PubMed ID: 17327374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line.
    Ghorbani-Anarkooli M; Dabirian S; Zendedel A; Moladoust H; Bahadori MH
    Acta Histochem; 2021 Apr; 123(3):151700. PubMed ID: 33667778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
    Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN
    Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer.
    Zhang L; Boufraqech M; Lake R; Kebebew E
    Oncotarget; 2016 Mar; 7(13):16517-28. PubMed ID: 26934320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
    Milošević Z; Banković J; Dinić J; Tsimplouli C; Sereti E; Dragoj M; Paunović V; Milovanović Z; Stepanović M; Tanić N; Dimas K; Pešić M
    Cell Oncol (Dordr); 2018 Aug; 41(4):409-426. PubMed ID: 29790111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
    Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
    Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.
    Fallahi P; Ferrari SM; La Motta C; Materazzi G; Bocci G; Da Settimo F; Miccoli P; Antonelli A
    Endocrine; 2016 Jul; 53(1):136-44. PubMed ID: 26286966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
    Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
    Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
    Chen G; Nicula D; Renko K; Derwahl M
    Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer.
    Gray KD; McCloskey JE; Vedvyas Y; Kalloo OR; Eshaky SE; Yang Y; Shevlin E; Zaman M; Ullmann TM; Liang H; Stefanova D; Christos PJ; Scognamiglio T; Tassler AB; Zarnegar R; Fahey TJ; Jin MM; Min IM
    Clin Cancer Res; 2020 Nov; 26(22):6003-6016. PubMed ID: 32887724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.